Assessment of antipsychotic-induced cytotoxic effects on isolated CD1 mouse pancreatic beta cells
Abstract
Objectives: The study aims to assess apoptosis, oxidative stress, and inflammation
as underlying diabetogenic mechanisms in isolated CD1 mouse beta-pancreatic cells
of some prescribed Antipsychotics (APs).
Methods: Three types of APs were tested in different concentrations (0.1, 1, 10, and
100 μM) on adult male CD1 mice. The cytotoxicity of the tested APs was determined
using different assays including MTT and Lactate Dehydrogenase (LDH) assays.
Oxidative stress was assessed by and measuring Reactive oxygen species (ROS)
production, lipid peroxidation, and antioxidant enzyme activities. Moreover, the effect
on the inflammatory cascade was also investigated.
Results: The tested APs were cytotoxic to beta cells and showed patterns dependent
on both concentration and exposure, with a parallel reduction in glucose-stimulated
insulin secretion of the treated cells. The APs also showed induction of oxidative stress
in the treated cells by significantly increasing the ROS, lipid peroxidation, and NRf2
gene expression, together with decreased antioxidant enzyme activities. Moreover,
APs showed significant increases in cytokines levels to their estimated IC50 levels.
The activities of caspases 3, 8, and 9 were also significantly increased in all treated
samples at their IC50s and at 10 μM concentrations of all tested APs. However, the
glutathione and inhibitors of caspase-3, IL-6, and TNF-α significantly improved GSIS
and the viability of the AP-treated cells.
Conclusion: The results suggest a significant role for apoptosis, oxidative stress,
and inflammation, in the diabetogenic effect of APs, expected role of antioxidants
and anti-inflammatory drugs as therapeutics for improving the outcome in cases of
long-term prescribed APs.
Keywords:
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).